|
06 Oct 2021 |
Apexigen Announces First Patient Dosed in Phase 3 Pivotal Trial for BD0801, an Anti-VEGF Monoclonal Antibody, in Combination Therapy for Ovarian Cancer
|
|
06 Oct 2021 |
Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal Influenza
|
|
06 Oct 2021 |
Dialectic Therapeutics Announces First-in-Human Dose in Phase 1 Clinical Trial Evaluating DT2216, its First Generation Antiapoptotic Protein Targeted Degradation (APTaD™) Compound, in Patients with Relapsed or Refractory Malignancies
|
|
06 Oct 2021 |
Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical Trial
|
|
06 Oct 2021 |
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older
|
|
06 Oct 2021 |
Precirix Dosed First Patients in Phase I/II Clinical Study Evaluating CAM-H2 in HER2-Positive Metastatic Cancer
|
|
06 Oct 2021 |
Intellia Therapeutics Receives Authorization to Initiate Phase 1/2 Clinical Trial of NTLA-2002 for the Treatment of Hereditary Angioedema
|
|
06 Oct 2021 |
Masked Antibodies and Cytokines as Prodrugs: strongly emerging novel technologies providing plenty of opportunities for founders, investors and partnerships
|
|
06 Oct 2021 |
Takeda Provides Update on TAK-994 Clinical Program
|
|
05 Oct 2021 |
Zymeworks and ALX Oncology Announce First Patient Dosed in Phase 1b/2 Clinical Trial of Zanidatamab and Evorpacept (ALX148) in Patients with Advanced HER2-Expressing Breast Cancer and Other Solid Tumors
|
|
05 Oct 2021 |
Exo Therapeutics Raises $78 Million Series B Financing
|
|
05 Oct 2021 |
IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies
|
|
05 Oct 2021 |
Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine
|
|
05 Oct 2021 |
AZD7442 request for Emergency Use Authorization for COVID-19 prophylaxis filed in US
|
|
04 Oct 2021 |
Adverum Presents 2-Year OPTIC Data Demonstrating Sustained Durability and Promising Safety Profile from Single Intravitreal Injection of ADVM-022 in Wet AMD Patients Who Previously Required Frequent Anti-VEGF Injections
|
|
04 Oct 2021 |
AnaptysBio Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in Generalized Pustular Psoriasis
|
|
04 Oct 2021 |
Sarepta Therapeutics Announces Initiation of EMBARK, a Global Pivotal Study of SRP-9001, a Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
|
|
04 Oct 2021 |
Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next-Generation Gene Therapies for Patients with Lysosomal Storage Disorders
|
|
04 Oct 2021 |
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
|
|
04 Oct 2021 |
Appello Pharmaceuticals Begins Phase 1 Clinical Trial
|
